Institutional shares held 20.3 Million
149K calls
26.3K puts
Total value of holdings $112M
$819K calls
$144K puts
Market Cap $401M
68,350,896 Shares Out.
Institutional ownership 29.7%
# of Institutions 122


Latest Institutional Activity in CDXC

Top Purchases

Q4 2024
D. E. Shaw & Co., Inc. Shares Held: 1.01M ($5.94M)
Q4 2024
Arrowstreet Capital, Limited Partnership Shares Held: 663K ($3.89M)
Q4 2024
Qube Research & Technologies LTD Shares Held: 347K ($2.04M)
Q4 2024
Connor, Clark & Lunn Investment Management Ltd. Shares Held: 506K ($2.97M)
Q4 2024
Cubist Systematic Strategies, LLC Shares Held: 310K ($1.82M)

Top Sells

Q4 2024
Tieton Capital Management, LLC Shares Held: 2.59M ($15.2M)
Q4 2024
Winton Group LTD Shares Held: 19.2K ($112K)
Q4 2024
Royal Bank Of Canada Shares Held: 111K ($649K)
Q4 2024
Vanguard Group Inc Shares Held: 3.39M ($19.9M)
Q4 2024
Jane Street Group, LLC Shares Held: 23.2K ($136K)

About CDXC

ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.


Insider Transactions at CDXC

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
11.5M Shares
From 4 Insiders
Open market or private purchase 11.4M shares
Exercise of conversion of derivative security 73K shares
Sell / Disposition
11.5M Shares
From 3 Insiders
Open market or private sale 11.5M shares

Track Institutional and Insider Activities on CDXC

Follow ChromaDex Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDXC shares.

Notify only if

Insider Trading

Get notified when an Chroma Dex Corp. insider buys or sells CDXC shares.

Notify only if

News

Receive news related to ChromaDex Corp.

Track Activities on CDXC